JORDEN DAVID EMERSON (CEO, CFO) received a stock award from NUO THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 8/29/2026ACC: 0001437749-26-029236
DirectorOfficer· CEO, CFO
Since Aug 2018
+8.77K
Net shares
Net buyer
$9.5K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
8.77K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+789.00
Price / share
$1.07
Trade value
$844.23
% of position
0.0%
8/27/2026
2.06M→2.06M
Common Stock
Direct
Shares
+7.98K
Price / share
$1.09
Trade value
$8.69K
% of position
0.4%
8/28/2026
2.06M→2.07M
Total
Net shares
+8.77K
Net value
$9.54K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/27/2026 | A · Award | +789.00 | $1.07 | $844.23 | 0.0% | 2.06M | 2.06M |
| Common Stock Direct | 8/28/2026 | A · Award | +7.98K | $1.09 | $8.69K | 0.4% | 2.06M | 2.07M |
| Total | +8.77K | $9.54K | ||||||
Derivative Transactions0
No derivative transactions reported